Franziska Bach receives Köln Fortune Stipend

Franziska Bach receives a Köln Fortune Stipend awarded by the University of Cologne. The Köln Fortune Program awards highly successful and motivated medical students to support their work during the doctoral thesis.

In her project, Franziska investigates new strategies of immune-mediated control of HIV-1 infection to identify a new treatment approach. To this end, Franziska combines state of the art in vitro and in vivo experiments using novel concepts in immunology.

Nov 29 2023

We are very happy to share our latest publication about SARS-CoV-2 neutralizing antibodies!

Congratulations to Michi, Matthias and Christoph, who investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies. » read more

Nov 21 2023

Congratulations to Timm, Svea and Sabrina for their study on SARS-CoV-2 humoral immunity!

This study shows that an enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool. » read more

Nov 14 2023

Congratulations Matthias and Artem on our study on neutralizing antibodies against HCMV!

This study provides a deep understanding of the mechanisms of HCMV neutralization and identifies promising antibody candidates to prevent and treat HCMV infection. » read more

Nov 13 2023

Congratulations to Philipp for his study on the dynamics of HIV-1 neutralization!

This study provides knowledge about the dynamics and durability of nAb response in humans which is crucial for the design of future HIV-1 vaccine regimens. » read more

Nov 04 2023

Our latest work on determining probabilities of antibody sequence development is now online

In this study, Christoph and his colleagues provide a framework to determine probabilities of antibody sequence development and show that uninfected and chronically infected individuals have the same chances to develop HIV-1 neutralizing antibodies. » read more

» News Archive